{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:57:53Z","timestamp":1790665073663,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,6,11]],"date-time":"2011-06-11T00:00:00Z","timestamp":1307750400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s10549-011-1616-x","type":"journal-article","created":{"date-parts":[[2011,6,10]],"date-time":"2011-06-10T12:10:10Z","timestamp":1307707810000},"page":"587-597","source":"Crossref","is-referenced-by-count":164,"title":["Risk factors by molecular subtypes of breast cancer across a population-based study of women 56\u00a0years or younger"],"prefix":"10.1007","volume":"130","author":[{"given":"Mia M.","family":"Gaudet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Press","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Haile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles F.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally L.","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joellen","family":"Schildkraut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilie D.","family":"Gammon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Douglas Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonine L.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,6,11]]},"reference":[{"issue":"19","key":"1616_CR1","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T Sorlie","year":"2001","unstructured":"Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P, Borresen-Dale AL (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98(19):10869\u201310874","journal-title":"Proc Natl Acad Sci USA"},{"key":"1616_CR2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1471-2164-7-127","volume":"7","author":"T Sorlie","year":"2006","unstructured":"Sorlie T, Wang Y, Xiao C, Johnsen H, Naume B, Samaha RR, Borresen-Dale AL (2006) Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms. BMC Genomics 7:127. doi: 10.1186\/1471-2164-7-127","journal-title":"BMC Genomics"},{"issue":"21","key":"1616_CR3","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","volume":"295","author":"LA Carey","year":"2006","unstructured":"Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295(21):2492\u20132502. doi: 10.1001\/jama.295.21.2492","journal-title":"JAMA"},{"issue":"8","key":"1616_CR4","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1158\/1078-0432.CCR-06-1109","volume":"13","author":"LA Carey","year":"2007","unstructured":"Carey LA, Dees EC, Sawyer L, Gatti L, Moore DT, Collichio F, Ollila DW, Sartor CI, Graham ML, Perou CM (2007) The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res 13(8):2329\u20132334. doi: 10.1158\/1078-0432.CCR-06-1109","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1616_CR5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10549-008-9926-3","volume":"113","author":"MJ Lund","year":"2009","unstructured":"Lund MJ, Trivers KF, Porter PL, Coates RJ, Leyland-Jones B, Brawley OW, Flagg EW, O\u2019Regan RM, Gabram SG, Eley JW (2009) Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat 113(2):357\u2013370. doi: 10.1007\/s10549-008-9926-3","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"1616_CR6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10549-007-9632-6","volume":"109","author":"RC Millikan","year":"2008","unstructured":"Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, Smith LV, Labbok MH, Geradts J, Bensen JT, Jackson S, Nyante S, Livasy C, Carey L, Earp HS, Perou CM (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109(1):123\u2013139. doi: 10.1007\/s10549-007-9632-6","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"1616_CR7","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/bcr2261","volume":"11","author":"ML Kwan","year":"2009","unstructured":"Kwan ML, Kushi LH, Weltzien E, Maring B, Kutner SE, Fulton RS, Lee MM, Ambrosone CB, Caan BJ (2009) Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res 11(3):R31. doi: 10.1186\/bcr2261","journal-title":"Breast Cancer Res"},{"issue":"21","key":"1616_CR8","doi-asserted-by":"crossref","first-page":"10608","DOI":"10.1158\/0008-5472.CAN-07-2142","volume":"67","author":"XR Yang","year":"2007","unstructured":"Yang XR, Pfeiffer RM, Garcia-Closas M, Rimm DL, Lissowska J, Brinton LA, Peplonska B, Hewitt SM, Cartun RW, Mandich D, Sasano H, Evans DB, Sutter TR, Sherman ME (2007) Hormonal markers in breast cancer: coexpression, relationship with pathologic characteristics, and risk factor associations in a population-based study. Cancer Res 67(21):10608\u201310617. doi: 10.1158\/0008-5472.CAN-07-2142","journal-title":"Cancer Res"},{"issue":"7","key":"1616_CR9","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/cncr.23786","volume":"113","author":"AI Phipps","year":"2008","unstructured":"Phipps AI, Malone KE, Porter PL, Daling JR, Li CI (2008) Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer. Cancer 113(7):1521\u20131526. doi: 10.1002\/cncr.23786","journal-title":"Cancer"},{"issue":"8","key":"1616_CR10","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1158\/1055-9965.EPI-08-0206","volume":"17","author":"AI Phipps","year":"2008","unstructured":"Phipps AI, Malone KE, Porter PL, Daling JR, Li CI (2008) Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 17(8):2078\u20132086. doi: 10.1158\/1055-9965.EPI-08-0206","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"1616_CR11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10552-006-0092-9","volume":"18","author":"WF Anderson","year":"2007","unstructured":"Anderson WF, Matsuno RK, Sherman ME, Lissowska J, Gail MH, Brinton LA, Yang XR, Peplonska B, Chen BE, Rosenberg PS, Chatterjee N, Szeszenia-Dabrowska N, Bardin-Mikolajczak A, Zatonski W, Devesa SS, Garcia-Closas M (2007) Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions. Cancer Causes Control 18(4):439\u2013447. doi: 10.1007\/s10552-006-0092-9","journal-title":"Cancer Causes Control"},{"issue":"10","key":"1616_CR12","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1158\/1055-9965.EPI-06-0191","volume":"15","author":"WF Anderson","year":"2006","unstructured":"Anderson WF, Pfeiffer RM, Dores GM, Sherman ME (2006) Comparison of age distribution patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev 15(10):1899\u20131905. doi: 10.1158\/1055-9965.EPI-06-0191","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"1616_CR13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/oxfordjournals.aje.a114942","volume":"128","author":"PA Wingo","year":"1988","unstructured":"Wingo PA, Ory HW, Layde PM, Lee NC (1988) The evaluation of the data collection process for a multicenter, population-based, case-control design. Am J Epidemiol 128(1):206\u2013217","journal-title":"Am J Epidemiol"},{"issue":"9","key":"1616_CR14","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0039-128X(02)00039-9","volume":"67","author":"M Press","year":"2002","unstructured":"Press M, Spaulding B, Groshen S, Kaminsky D, Hagerty M, Sherman L, Christensen K, Edwards DP (2002) Comparison of different antibodies for detection of progesterone receptor in breast cancer. Steroids 67(9):799\u2013813","journal-title":"Steroids"},{"issue":"4","key":"1616_CR15","first-page":"480","volume":"50","author":"MF Press","year":"1984","unstructured":"Press MF, Greene GL (1984) An immunocytochemical method for demonstrating estrogen receptor in human uterus using monoclonal antibodies to human estrophilin. Lab Invest 50(4):480\u2013486","journal-title":"Lab Invest"},{"issue":"10","key":"1616_CR16","first-page":"2771","volume":"54","author":"MF Press","year":"1994","unstructured":"Press MF, Hung G, Godolphin W, Slamon DJ (1994) Sensitivity of HER-2\/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression. Cancer Res 54(10):2771\u20132777","journal-title":"Cancer Res"},{"issue":"14","key":"1616_CR17","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1200\/JCO.2002.09.094","volume":"20","author":"MF Press","year":"2002","unstructured":"Press MF, Slamon DJ, Flom KJ, Park J, Zhou JY, Bernstein L (2002) Evaluation of HER-2\/neu gene amplification and overexpression: comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens. J Clin Oncol 20(14):3095\u20133105","journal-title":"J Clin Oncol"},{"issue":"4","key":"1616_CR18","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/1055-9965.EPI-08-1005","volume":"18","author":"JM Dolle","year":"2009","unstructured":"Dolle JM, Daling JR, White E, Brinton LA, Doody DR, Porter PL, Malone KE (2009) Risk factors for triple-negative breast cancer in women under the age of 45\u00a0years. Cancer Epidemiol Biomarkers Prev 18(4):1157\u20131166. doi: 10.1158\/1055-9965.EPI-08-1005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"1616_CR19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1158\/1055-9965.EPI-06-0806","volume":"16","author":"XR Yang","year":"2007","unstructured":"Yang XR, Sherman ME, Rimm DL, Lissowska J, Brinton LA, Peplonska B, Hewitt SM, Anderson WF, Szeszenia-Dabrowska N, Bardin-Mikolajczak A, Zatonski W, Cartun R, Mandich D, Rymkiewicz G, Ligaj M, Lukaszek S, Kordek R, Garcia-Closas M (2007) Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev 16(3):439\u2013443. doi: 10.1158\/1055-9965.EPI-06-0806","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"1616_CR20","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1158\/0008-5472.CAN-09-3460","volume":"70","author":"H Ma","year":"2010","unstructured":"Ma H, Wang Y, Sullivan-Halley J, Weiss L, Marchbanks PA, Spirtas R, Ursin G, Burkman RT, Simon MS, Malone KE, Strom BL, McDonald JA, Press MF, Bernstein L (2010) Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women\u2019s contraceptive and reproductive experiences study. Cancer Res 70(2):575\u2013587. doi: 10.1158\/0008-5472.CAN-09-3460","journal-title":"Cancer Res"},{"issue":"2","key":"1616_CR21","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1158\/1055-9965.EPI-08-0805","volume":"18","author":"H Ma","year":"2009","unstructured":"Ma H, Luo J, Press MF, Wang Y, Bernstein L, Ursin G (2009) Is there a difference in the association between percent mammographic density and subtypes of breast cancer? Luminal A and triple-negative breast cancer. Cancer Epidemiol Biomarkers Prev 18(2):479\u2013485. doi: 10.1158\/1055-9965.EPI-08-0805","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"1616_CR22","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/cncr.22618","volume":"109","author":"KR Bauer","year":"2007","unstructured":"Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer 109(9):1721\u20131728. doi: 10.1002\/cncr.22618","journal-title":"Cancer"},{"issue":"22","key":"1616_CR23","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1093\/jnci\/djn344","volume":"100","author":"LA Brinton","year":"2008","unstructured":"Brinton LA, Sherman ME, Carreon JD, Anderson WF (2008) Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst 100(22):1643\u20131648. doi: 10.1093\/jnci\/djn344","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"1616_CR24","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1309\/AJCPV2I0HGPMGBSQ","volume":"132","author":"F Penault-Llorca","year":"2009","unstructured":"Penault-Llorca F, Bilous M, Dowsett M, Hanna W, Osamura RY, Ruschoff J, van de Vijver M (2009) Emerging technologies for assessing HER2 amplification. Am J Clin Pathol 132(4):539\u2013548. doi: 10.1309\/AJCPV2I0HGPMGBSQ","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"1616_CR25","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/labinvest.3700131","volume":"84","author":"KA DiVito","year":"2004","unstructured":"DiVito KA, Charette LA, Rimm DL, Camp RL (2004) Long-term preservation of antigenicity on tissue microarrays. Lab Invest 84(8):1071\u20131078. doi: 10.1038\/labinvest.3700131","journal-title":"Lab Invest"},{"issue":"4","key":"1616_CR26","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1158\/1055-9965.667.13.4","volume":"13","author":"JH Fergenbaum","year":"2004","unstructured":"Fergenbaum JH, Garcia-Closas M, Hewitt SM, Lissowska J, Sakoda LC, Sherman ME (2004) Loss of antigenicity in stored sections of breast cancer tissue microarrays. Cancer Epidemiol Biomarkers Prev 13(4):667\u2013672","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"1616_CR27","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1158\/1055-9965.EPI-10-0056","volume":"19","author":"ME Sherman","year":"2011","unstructured":"Sherman ME, Howatt W, Blows FM, Pharoah P, Hewitt SM, Garcia-Closas M (2011) Molecular pathology in epidemiologic studies: a primer on key considerations. Cancer Epidemiol Biomarkers Prev 19(4):966\u2013972. doi: 10.1158\/1055-9965.EPI-10-0056","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6797","key":"1616_CR28","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D (2000) Molecular portraits of human breast tumours. Nature 406(6797):747\u2013752","journal-title":"Nature"},{"issue":"9017","key":"1616_CR29","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","volume":"347","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1996","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer (1996) Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 347(9017):1713\u20131727","journal-title":"Lancet"},{"issue":"9328","key":"1616_CR30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0140-6736(02)09454-0","volume":"360","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"2002","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer (2002) Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 360(9328):187\u2013195","journal-title":"Lancet"},{"issue":"3","key":"1616_CR31","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/oxfordjournals.aje.a114405","volume":"124","author":"A McTiernan","year":"1986","unstructured":"McTiernan A, Thomas DB (1986) Evidence for a protective effect of lactation on risk of breast cancer in young women. Results from a case-control study. Am J Epidemiol 124(3):353\u2013358","journal-title":"Am J Epidemiol"},{"issue":"5","key":"1616_CR32","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ijc.2910400502","volume":"40","author":"NL Petrakis","year":"1987","unstructured":"Petrakis NL, Wrensch MR, Ernster VL, Miike R, Murai J, Simberg N, Siiteri PK (1987) Influence of pregnancy and lactation on serum and breast fluid estrogen levels: implications for breast cancer risk. Int J Cancer 40(5):587\u2013591","journal-title":"Int J Cancer"},{"issue":"1","key":"1616_CR33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1242\/dev.122.1.181","volume":"122","author":"LR Lund","year":"1996","unstructured":"Lund LR, Romer J, Thomasset N, Solberg H, Pyke C, Bissell MJ, Dano K, Werb Z (1996) Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways. Development 122(1):181\u2013193","journal-title":"Development"},{"issue":"1","key":"1616_CR34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/oxfordjournals.epirev.a036102","volume":"15","author":"MC Pike","year":"1993","unstructured":"Pike MC, Spicer DV, Dahmoush L, Press MF (1993) Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15(1):17\u201335","journal-title":"Epidemiol Rev"},{"issue":"8979","key":"1616_CR35","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0140-6736(95)92713-1","volume":"346","author":"BS Hulka","year":"1995","unstructured":"Hulka BS, Stark AT (1995) Breast cancer: cause and prevention. Lancet 346(8979):883\u2013887","journal-title":"Lancet"},{"issue":"1","key":"1616_CR36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/13813450801954303","volume":"114","author":"AG Renehan","year":"2008","unstructured":"Renehan AG, Roberts DL, Dive C (2008) Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem 114(1):71\u201383. doi: 10.1080\/13813450801954303","journal-title":"Arch Physiol Biochem"},{"issue":"11","key":"1616_CR37","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/jnci\/88.11.756","volume":"88","author":"N Potischman","year":"1996","unstructured":"Potischman N, Swanson CA, Siiteri P, Hoover RN (1996) Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst 88(11):756\u2013758","journal-title":"J Natl Cancer Inst"},{"issue":"16","key":"1616_CR38","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/jnci\/djg022","volume":"95","author":"TJ Key","year":"2003","unstructured":"Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C, Stanczyk FZ, Stephenson HE Jr, Falk RT, Miller R, Schatzkin A, Allen DS, Fentiman IS, Wang DY, Dowsett M, Thomas HV, Hankinson SE, Toniolo P, Akhmedkhanov A, Koenig K, Shore RE, Zeleniuch-Jacquotte A, Berrino F, Muti P, Micheli A, Krogh V, Sieri S, Pala V, Venturelli E, Secreto G, Barrett-Connor E, Laughlin GA, Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE, Cauley JA, Kuller LH, Cummings SR, Helzlsouer KJ, Alberg AJ, Bush TL, Comstock GW, Gordon GB, Miller SR (2003) Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95(16):1218\u20131226","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"1616_CR39","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/ijc.20315","volume":"111","author":"PH Lahmann","year":"2004","unstructured":"Lahmann PH, Hoffmann K, Allen N, van Gils CH, Khaw KT, Tehard B, Berrino F, Tjonneland A, Bigaard J, Olsen A, Overvad K, Clavel-Chapelon F, Nagel G, Boeing H, Trichopoulos D, Economou G, Bellos G, Palli D, Tumino R, Panico S, Sacerdote C, Krogh V, Peeters PH, Bueno-de-Mesquita HB, Lund E, Ardanaz E, Amiano P, Pera G, Quiros JR, Martinez C, Tormo MJ, Wirfalt E, Berglund G, Hallmans G, Key TJ, Reeves G, Bingham S, Norat T, Biessy C, Kaaks R, Riboli E (2004) Body size and breast cancer risk: findings from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 111(5):762\u2013771","journal-title":"Int J Cancer"},{"issue":"3","key":"1616_CR40","doi-asserted-by":"crossref","first-page":"s858","DOI":"10.1093\/ajcn\/86.3.858S","volume":"86","author":"D Barb","year":"2007","unstructured":"Barb D, Williams CJ, Neuwirth AK, Mantzoros CS (2007) Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am J Clin Nutr 86(3):s858\u2013s866","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"1616_CR41","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1210\/en.2009-0070","volume":"150","author":"MP Cleary","year":"2009","unstructured":"Cleary MP, Grossmann ME (2009) Minireview: obesity and breast cancer: the estrogen connection. Endocrinology 150(6):2537\u20132542. doi: 10.1210\/en.2009-0070","journal-title":"Endocrinology"},{"issue":"6","key":"1616_CR42","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/sj.ijo.0801998","volume":"26","author":"BA Stoll","year":"2002","unstructured":"Stoll BA (2002) Upper abdominal obesity, insulin resistance and breast cancer risk. Int J Obes Relat Metab Disord 26(6):747\u2013753","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"4","key":"1616_CR43","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3109\/00313029109063590","volume":"23","author":"MG Cook","year":"1991","unstructured":"Cook MG, Rohan TE (1991) Benign breast disease: the relationship between its histological features and risk factors for breast cancer. Pathology 23(4):286\u2013290","journal-title":"Pathology"},{"issue":"19","key":"1616_CR44","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/jnci\/djg050","volume":"95","author":"WD Foulkes","year":"2003","unstructured":"Foulkes WD, Stefansson IM, Chappuis PO, Begin LR, Goffin JR, Wong N, Trudel M, Akslen LA (2003) Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 95(19):1482\u20131485","journal-title":"J Natl Cancer Inst"},{"issue":"23","key":"1616_CR45","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/jnci\/djj500","volume":"98","author":"K Offit","year":"2006","unstructured":"Offit K (2006) BRCA mutation frequency and penetrance: new data, old debate. J Natl Cancer Inst 98(23):1675\u20131677. doi: 10.1093\/jnci\/djj500","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"1616_CR46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/bcr2476","volume":"12","author":"N Mavaddat","year":"2010","unstructured":"Mavaddat N, Pharoah PD, Blows F, Driver KE, Provenzano E, Thompson D, Macinnis RJ, Shah M, Search SO, Easton DF, Antoniou AC (2010) Familial relative risks for breast cancer by pathological subtype: a population-based cohort study. Breast Cancer Res 12(1):10. doi: 10.1186\/bcr2476","journal-title":"Breast Cancer Res"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-011-1616-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-011-1616-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-011-1616-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T09:04:03Z","timestamp":1686128643000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-011-1616-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,11]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["1616"],"URL":"https:\/\/doi.org\/10.1007\/s10549-011-1616-x","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,11]]}}}